StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 05 - 25
1
2022 - 07 - 25
1
2022 - 06 - 17
1
2022 - 01 - 06
1
2021 - 12 - 22
1
2021 - 12 - 14
1
2021 - 12 - 06
1
2021 - 11 - 04
1
Sector
Electronic technology
1
Health technology
8
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Abbott laboratories
1
Abbvie inc.
1
Amgen inc.
1
Becton, dickinson and company
1
Boston scientific corporation
1
Eli lilly and company
1
General electric company
1
Incyte corporation
1
Lantheus holdings, inc.
1
Novartis ag
8
Sanofi
2
Symbols
AAPL
4
ABB
12
ABBV
8
ABLZF
12
ABT
6
ALB
24
ALLO
4
AMGN
4
AMSIY
4
AMSYF
4
ARCXF
4
ARVL
7
AVGO
4
BIIB
5
BMY
5
BSX
5
CAJFF
4
CSSE
6
DEO
5
DNZOF
6
DNZOY
6
DOW
8
ERIC
5
FMC
6
FNCTF
25
GE
7
GOOG
5
GOOGL
5
GSK
7
HON
11
HUBS
22
HUN
8
IBM
5
IFNNF
7
IFNNY
6
INTC
5
JNJ
11
KAR
6
LAC
8
LIN
5
LITM
6
LLY
13
LMAT
6
LTUM
8
MMM
10
MRNA
5
MS
6
NMRD
6
NVS
8
NVSEF
8
OLMA
8
PFE
10
PHG
6
RYDAF
8
SAP
7
SAPGF
7
SNY
23
SNYNF
17
VCNX
5
VZ
5
Exchanges
Nasdaq
8
Nyse
8
Crawled Date
2023 - 05 - 25
1
2022 - 07 - 25
1
2022 - 06 - 17
1
2022 - 01 - 06
1
2021 - 12 - 22
1
2021 - 12 - 14
1
2021 - 12 - 06
1
2021 - 11 - 04
1
Crawled Time
01:00
1
06:00
3
07:00
1
12:00
1
15:00
1
15:15
1
Source
www.globenewswire.com
5
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Ema
symbols :
Nvsef
save search
Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published:
2023-05-25
(Crawled : 06:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.08%
|
O:
-0.49%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-6.95%
|
O:
-1.37%
H:
0.0%
C:
-0.89%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
20.61%
|
O:
-0.55%
H:
0.0%
C:
-1.2%
biosimilar
authorization
ema
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published:
2022-07-25
(Crawled : 06:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
34.65%
|
O:
3.12%
H:
0.06%
C:
0.06%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
8.4%
|
O:
0.06%
H:
0.31%
C:
0.19%
fda
biosimilar
ema
sclerosis
multiple sclerosis
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Published:
2022-06-17
(Crawled : 06:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
38.93%
|
O:
0.74%
H:
0.52%
C:
-3.23%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
14.31%
|
O:
0.07%
H:
0.0%
C:
0.0%
biosimilar
ema
application
Fluorine-18 Market to Exceed US$ 3 Bn by 2030; Surge in Use of PET/CT Scan in Oncology Spurs Demand for FDGs, Notes Study by TMR
Published:
2022-01-06
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
6.62%
|
O:
-0.1%
H:
0.82%
C:
0.7%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
5.74%
|
O:
0.75%
H:
0.16%
C:
-0.45%
GE
|
$152.94
-1.75%
0.0%
6M
|
Electronic Technology
|
55.83%
|
O:
0.91%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
179.26%
|
O:
-2.81%
H:
0.0%
C:
0.0%
LNTH
|
News
|
$62.34
1.4%
1.38%
1.3M
|
Health Technology
|
124.05%
|
O:
-1.42%
H:
2.7%
C:
2.11%
ema
scan
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Published:
2021-12-22
(Crawled : 07:00)
- globenewswire.com
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
8.25%
|
O:
-0.55%
H:
0.99%
C:
0.92%
ema
application
authorization
biosimilar
Female Infertility Drugs Market to Grow by USD 538.69 mn | AbbVie Inc. and Aurobindo Pharma Ltd. Among Key Vendors | Technavio
Published:
2021-12-14
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-5.03%
|
O:
-3.62%
H:
0.0%
C:
-0.56%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
16.83%
|
O:
0.69%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.2%
|
O:
0.17%
H:
0.5%
C:
-0.43%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
30.93%
|
O:
0.49%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-5.12%
|
O:
-0.51%
H:
0.0%
C:
0.0%
ema
drug
pharma
BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
Published:
2021-12-06
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.51%
|
O:
-4.23%
H:
0.11%
C:
0.11%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
18.68%
|
O:
2.02%
H:
0.04%
C:
-0.89%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.3%
|
O:
-0.57%
H:
0.0%
C:
0.0%
BSX
|
$67.42
-0.8%
-0.53%
5.9M
|
Health Technology
|
71.07%
|
O:
0.04%
H:
0.0%
C:
0.0%
BDX
|
$233.15
0.41%
0.15%
890K
|
Health Technology
|
-5.29%
|
O:
0.68%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-16.5%
|
O:
1.15%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-2.84%
|
O:
0.02%
H:
0.0%
C:
0.0%
ema
diabetes
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published:
2021-11-04
(Crawled : 15:15)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
11.81%
|
O:
0.18%
H:
0.0%
C:
-0.89%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
11.35%
|
O:
-0.06%
H:
0.28%
C:
0.18%
INCY
|
$52.82
0.19%
0.19%
1.8M
|
Health Technology
|
-18.39%
|
O:
2.41%
H:
0.0%
C:
0.0%
ema
car-t
platform
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.